Clinical Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Scalp Psoriasis

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 2e50b99004f3611a2821d8c6c1c7daf2fa9b3268
First added on: Oct 10, 2026